BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ampuero J, Romero-Gomez M. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin. World J Hepatol 2015; 7(8): 1105-1111 [PMID: 26052399 DOI: 10.4254/wjh.v7.i8.1105]
URL: https://www.wjgnet.com/1948-5182/full/v7/i8/1105.htm
Number Citing Articles
1
José A. del Campo, Marta García-Valdecasas, Antonio Gil-Gómez, Ángela Rojas, Paloma Gallego, Javier Ampuero, Rocío Gallego-Durán, Helena Pastor, Lourdes Grande, Francisco J. Padillo, Jordi Muntané, Manuel Romero-Gómez, Matias A Avila. Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagyPLOS ONE 2018; 13(1): e0191805 doi: 10.1371/journal.pone.0191805
2
Nan Cai, Shu-Juan Xie, Dong-Bo Qiu, Chang-Chang Jia, Cong Du, Wei Liu, Jia-Jie Chen, Qi Zhang. Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinomaJournal of Functional Foods 2016; 26: 309 doi: 10.1016/j.jff.2016.08.014
3
Allison J. Kasmari, Amy Welch, Guodong Liu, Doug Leslie, Thomas McGarrity, Thomas Riley. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic SyndromeThe American Journal of Medicine 2017; 130(6): 746.e1 doi: 10.1016/j.amjmed.2016.12.029
4
Shu-Xiang Cui, Wen-Na Shi, Zhi-Yu Song, Shu-Qing Wang, Xin-Feng Yu, Zu-Hua Gao, Xian-Jun Qu. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathwaysOncotarget 2016; 7(24): 36767 doi: 10.18632/oncotarget.9168
5
Alexander Kusnik, Nicole Hunter, Erik Rasbach, Thomas Miethke, Christoph Reissfelder, Matthias Philip Ebert, Andreas Teufel. Co-Medication and Nutrition in Hepatocellular Carcinoma: Potentially Preventative Strategies in Hepatocellular CarcinomaDigestive Diseases 2021; 39(5): 526 doi: 10.1159/000514277
6
Rebecca Baqiyyah N. Conway, Staci Sudenga, Donald McClain, William J. Blot. Diabetes and liver cancer risk: A stronger effect in Whites than Blacks?Journal of Diabetes and its Complications 2021; 35(3): 107816 doi: 10.1016/j.jdiacomp.2020.107816
7
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular CarcinomaResearch Journal of Pharmacy and Technology 2023; : 377 doi: 10.52711/0974-360X.2023.00065
8
Svenja Nölting, Julian Maurer, Gerald Spöttl, Elke Tatjana Aristizabal Prada, Clemens Reuther, Karen Young, Márta Korbonits, Burkhard Göke, Ashley Grossman, Christoph J. Auernhammer, Olorunseun Ogunwobi. Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling PathwaysPLOS ONE 2015; 10(12): e0143830 doi: 10.1371/journal.pone.0143830
9
Hyun-seok Kim, Hashem B. El-Serag. The Epidemiology of Hepatocellular Carcinoma in the USACurrent Gastroenterology Reports 2019; 21(4) doi: 10.1007/s11894-019-0681-x
10
Teodor T. Postolache, Deborah R. Medoff, Clayton H. Brown, Li Juan Fang, Sanjaya K. Upadhyaya, Christopher A. Lowry, Michael Miller, Julie A. Kreyenbuhl. Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorderPteridines 2021; 32(1): 48 doi: 10.1515/pteridines-2020-0028
11
Undurti N. Das. Bioactive Lipids as Mediators of the Beneficial Actions of StatinsJournal of Cardiovascular Pharmacology 2019; 74(1): 4 doi: 10.1097/FJC.0000000000000689
12
Liang Gu, Sourav Taru Saha, Jodie Thomas, Mandeep Kaur. Targeting cellular cholesterol for anticancer therapyThe FEBS Journal 2019; 286(21): 4192 doi: 10.1111/febs.15018
13
Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu. The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.863352
14
Jelena Todoric, Laura Antonucci, Michael Karin. Targeting Inflammation in Cancer Prevention and TherapyCancer Prevention Research 2016; 9(12): 895 doi: 10.1158/1940-6207.CAPR-16-0209
15
Ibrahim El Sayed, Maged W. Helmy, Hanan S. El-Abhar. Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinomaLife Sciences 2018; 213: 248 doi: 10.1016/j.lfs.2018.10.002
16
Sung-Wan Kim, Hee-Ju Kang, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Adam J. Walker, Bruno Agustini, Jae-Min Kim, Michael Berk. Statins and Inflammation: New Therapeutic Opportunities in PsychiatryFrontiers in Psychiatry 2019; 10 doi: 10.3389/fpsyt.2019.00103
17
Shujuan Ma, Yixiang Zheng, Yanni Xiao, Pengcheng Zhou, Hongzhuan Tan. Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patientsMedicine 2017; 96(19): e6888 doi: 10.1097/MD.0000000000006888
18
R. N. Mustafin. Possibilities of using statins in comprehensive antitumor treatmentMD-Onco 2022; 2(3): 59 doi: 10.17650/2782-3202-2022-2-3-59-64
19
Pedro E. Lázaro-Mixteco, José M. González-Coronel, Laura Hernández-Padilla, Lorena Martínez-Alcantar, Enrique Martínez-Carranza, Jesús Salvador López-Bucio, Ángel A. Guevara-García, Jesús Campos-García. Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix AdenocarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.790537
20
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, Marco Cintoni, Maria Cristina Mele, Maurizio Pompili, Antonio Gasbarrini. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future PerspectivesJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00002
21
R. N. Mustafin. Prospects for the use of statins in the treatment of neurofibromatosis type 1Advances in Molecular Oncology 2022; 9(3): 15 doi: 10.17650/2313-805X-2022-9-3-15-23
22
Ángela Rojas, María Rosario García-Lozano, Antonio Gil-Gómez, Manuel Romero-Gómez, Javier Ampuero. Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel TherapiesJournal of Clinical and Translational Hepatology 2022; 10(2): 356 doi: 10.14218/JCTH.2021.00247
23
Harvey J. Murff, Christianne L. Roumie, Robert A. Greevy, Amber J. Hackstadt, Lucy E. D’Agostino McGowan, Adriana M. Hung, Carlos G. Grijalva, Marie R. Griffin. Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancerCancer Causes & Control 2018; 29(9): 823 doi: 10.1007/s10552-018-1058-4
24
Samir Agrawal, Padman Vamadevan, Ndaba Mazibuko, Robin Bannister, Raphael Swery, Shanna Wilson, Sarah Edwards. A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00681